Article
Covance, Medable form decentralized trial partnership
June 11, 2020
Covance, the drug development business division of LabCorp, announced it was working to expand its technology offerings with solutions intended to speed the industry adoption of decentralized and hybrid trials. The company plans to partner with Medable, a provider of software for digital clinical trials.The two companies will be working together to come up with solutions designed to accelerate adoption of decentralized clinical trial technology.
